NUP100 Antibody

What is NUP100 and why is it significant in research?

NUP100 is a nucleoporin protein forming part of the nuclear pore complex (NPC), which regulates transport between the nucleus and cytoplasm. Its significance in research stems from its critical role in tRNA export and its impact on replicative life span, particularly in Saccharomyces cerevisiae. Studies have shown that deletion of NUP100 increases replicative life span through mechanisms involving nuclear tRNA accumulation . Understanding NUP100 function provides insights into fundamental cellular processes including nucleocytoplasmic transport, aging, and gene expression regulation.

What are the key structural domains of NUP100 relevant for antibody targeting?

The GLFG (glycine-leucine-phenylalanine-glycine) domain of NUP100 is particularly important for its biological function. Research demonstrates that deletion of this specific domain is sufficient to inhibit tRNA export, similar to effects observed with complete NUP100 deletion . When selecting or designing NUP100 antibodies, targeting this domain can be particularly informative for functional studies. Other domains in NUP100 do not significantly impact tRNA dynamics, making the GLFG domain a primary target for antibody development and experimental interventions.

How do NUP100 antibodies differ from antibodies against other nucleoporins?

NUP100 antibodies specifically recognize epitopes on the NUP100 protein, which localizes to particular regions within the nuclear pore complex. Unlike antibodies against nucleoporins such as NUP214 (which is positioned at the cytoplasmic side of the NPC and serves as a docking site for receptor-mediated import) or NUP107 (which is found in both cytoplasmic and nucleoplasmic rings) , NUP100 antibodies target a protein primarily involved in tRNA export. The selectivity of these antibodies enables researchers to distinguish between different nucleoporins that may have overlapping but distinct functions within the complex architecture of the NPC.

What are the recommended applications for NUP100 antibodies in yeast research?

For yeast research, NUP100 antibodies are primarily used in immunofluorescence microscopy to visualize the localization of NUP100 within the nuclear envelope. When combined with fluorescence in situ hybridization (FISH) techniques, these antibodies enable correlation between NUP100 localization and tRNA distribution patterns . Western blotting is also effective for detecting NUP100 protein levels, particularly when examining mutant strains or genetic manipulations. For co-immunoprecipitation experiments, NUP100 antibodies can help identify interaction partners involved in tRNA export pathways or other nucleoporins within the same complex.

How can I optimize immunofluorescence protocols for NUP100 detection in nuclear pore complexes?

For optimal immunofluorescence detection of NUP100 in nuclear pore complexes, consider implementing the Nuclei-Isolation Staining (NIS) method which enhances antibody nuclear accessibility. This technique reduces background signal and improves imaging quality by removing cytoplasmic proteins that may contribute to non-specific binding . When visualizing NUP100 as part of the nuclear pore complex architecture, use advanced microscopy techniques such as STORM (Stochastic Optical Reconstruction Microscopy) to achieve resolution below 25 nm, which allows visualization of individual NPCs . For consistent results across experiments, standardize fixation protocols (typically 4% paraformaldehyde for 15-20 minutes) and permeabilization steps (0.1-0.5% Triton X-100 for 5-10 minutes).

What controls should be included when performing Western blots with NUP100 antibodies?

When performing Western blots with NUP100 antibodies, several controls are essential:

• Positive control: Include lysates from wild-type cells known to express NUP100

• Negative control: Use lysates from NUP100 deletion mutants (nup100Δ)

• Loading control: Probe for a housekeeping protein (e.g., actin or GAPDH) to ensure equal protein loading

• Antibody specificity control: Include samples from cells expressing NUP100 with mutations in the antibody epitope region

• Concentration gradient: Run multiple concentrations of lysate (e.g., 5 μg, 15 μg, and 50 μg) to ensure detection is within the linear range

For optimal detection on 4-8% SDS-PAGE gels, use antibody concentrations around 0.04 μg/mL and validate results across different cell lines when possible .

How can NUP100 antibodies be used to investigate the relationship between tRNA export and cellular aging?

To investigate the relationship between tRNA export and cellular aging using NUP100 antibodies, combine immunofluorescence with FISH techniques to simultaneously visualize NUP100 localization and tRNA distribution. This approach enables quantification of nuclear-to-cytoplasmic (N:C) ratios of specific tRNAs in wild-type versus nup100Δ cells . To establish causality between tRNA export and aging, researchers should analyze replicative life span measurements in parallel with molecular analyses. For mechanistic insights, examine Gcn4 protein levels using NUP100 antibodies in conjunction with Gcn4-lacZ reporter assays, as increased Gcn4 has been linked to longevity in strains with tRNA export defects . Cross-compare results with other nucleoporin mutants (e.g., los1Δ or msn5Δ) to establish specific versus general effects of disrupting the nuclear pore complex.

What advanced microscopy techniques can maximize the resolution of NUP100 within the nuclear pore complex?

For maximum resolution of NUP100 within the nuclear pore complex, implement Pan-Expansion Microscopy (Pan-ExM) combined with STORM imaging. This approach can achieve resolution below 25 nm, allowing visualization of individual nuclear pore complexes and precise localization of NUP100 relative to other nucleoporins . The technique involves:

• Sample expansion using a polymer matrix

• NUP100 antibody labeling post-expansion

• Super-resolution imaging using STORM or similar techniques

This methodology enables researchers to resolve the three-dimensional organization of NUP100 within the NPC architecture and quantify its association with specific substructures. For multicolor imaging, combine NUP100 antibodies with antibodies against other nucleoporins (e.g., NUP107 for ring structures or NUP153 for nuclear basket) to create comprehensive maps of relative positioning .

How can I design experiments to study the functional consequences of NUP100 domain mutations using antibodies?

To study functional consequences of NUP100 domain mutations using antibodies, design experiments that compare wild-type NUP100 with domain-specific mutants, particularly focusing on the GLFG domain. Begin by creating expression constructs with specific domain deletions (e.g., nup100Δ GLFG) and transform them into nup100Δ cells . Use domain-specific antibodies to confirm expression and localization of mutant proteins by immunofluorescence and Western blotting.

To assess functional consequences:

• Perform tRNA FISH experiments to quantify nuclear accumulation of specific tRNAs (tRNA ile, tRNA tyr, tRNA trp) in different mutants

• Measure Gcn4 protein levels using Western blot or reporter assays

• Conduct replicative life span analyses to correlate molecular changes with cellular aging phenotypes

• Use co-immunoprecipitation with NUP100 antibodies to identify changes in protein interactions resulting from domain mutations

Compare results across different genetic backgrounds (e.g., BY4741 vs. W303) to ensure phenotypes are not strain-specific .

What are common issues with NUP100 antibody specificity and how can they be addressed?

Common issues with NUP100 antibody specificity include cross-reactivity with other nucleoporins, high background signal, and inconsistent detection across different experimental systems. To address these challenges:

• Validate antibody specificity using knockout/knockdown controls (nup100Δ cells)

• Pre-adsorb antibodies with cell lysates from knockout models to reduce non-specific binding

• Optimize blocking conditions (try 5% BSA instead of milk for phosphorylated epitopes)

• Use epitope-specific antibodies targeting unique regions of NUP100

• For mammalian systems, consider potential homology with other nucleoporins and validate results with multiple antibodies recognizing different epitopes

When inconsistent results occur between immunofluorescence and Western blot applications, this may indicate epitope masking in one context. In such cases, try different fixation methods or antibody clones recognizing different regions of the protein.

How can I improve signal-to-noise ratio when using NUP100 antibodies for nuclear pore visualization?

To improve signal-to-noise ratio when visualizing nuclear pores with NUP100 antibodies:

• Implement the Nuclei-Isolation Staining (NIS) method to enhance nuclear accessibility and reduce cytoplasmic background

• Use concentration gradients to determine optimal primary antibody dilutions (typical range: 1:100 to 1:1000)

• Extend primary antibody incubation time (overnight at 4°C) while reducing concentration

• Include 0.1-0.2% Triton X-100 in antibody diluent to improve penetration

• Apply multi-step detection methods such as biotin-streptavidin amplification for weak signals

• For confocal microscopy, optimize pinhole settings to minimize out-of-focus signal

• Post-acquisition, apply deconvolution algorithms specifically designed for nuclear envelope structures

When working with highly differentiated cells, the NIS method is particularly valuable for equalizing antibody-labeling efficiency between different cell states .

What strategies can overcome challenges in detecting NUP100 in different species or cell types?

Detecting NUP100 across different species or cell types presents challenges due to sequence variations and expression levels. To overcome these challenges:

• For cross-species applications, select antibodies targeting conserved epitopes by performing sequence alignments

• In mammalian systems, focus on the NUP98-96 homolog and verify specificity across multiple cell lines

• Adjust lysis buffers according to cell type (e.g., stronger detergents for yeast cells with cell walls)

• For difficult-to-permeabilize cells, test graduated ethanol series or methanol fixation instead of standard paraformaldehyde

• In tissue sections, implement antigen retrieval methods (heat-induced or enzymatic)

• For low-expression contexts, use signal amplification methods such as tyramide signal amplification (TSA)

When working with primary tissues, always validate antibody performance using positive control samples where NUP100 expression has been confirmed by other methods such as RNA sequencing data.

How should researchers quantify and interpret NUP100 immunofluorescence patterns at the nuclear envelope?

For quantitative analysis of NUP100 immunofluorescence patterns:

• Calculate the nuclear-to-cytoplasmic (N:C) fluorescence intensity ratio using line scans across the nuclear envelope

• For nuclear pore density measurements, count distinct NUP100-positive puncta per unit area of nuclear envelope

• Compare intensities between experimental conditions using standardized exposure settings and acquisition parameters

• For co-localization studies with other nucleoporins, calculate Pearson's or Mander's coefficients

• When examining tRNA export, correlate NUP100 staining patterns with tRNA distribution using dual-label approaches

Significant increases in the N:C ratio of specific tRNAs (e.g., 1.47 in wild type vs. 1.81 in nup100Δ cells for tRNA ile) indicate export defects . Compare these patterns with control nucleoporins like Los1 or Msn5 to distinguish NUP100-specific effects from general NPC disruption.

What statistical approaches are recommended for analyzing NUP100 antibody data in comparative studies?

For statistical analysis of NUP100 antibody data in comparative studies:

• For immunofluorescence intensity comparisons, use paired t-tests when comparing different regions within the same cells or ANOVA for multi-group comparisons

• For nuclear pore counts or distribution analyses, apply non-parametric tests (Mann-Whitney or Kruskal-Wallis) as these data often do not follow normal distributions

• In life span correlation studies, use Kaplan-Meier survival analysis with log-rank tests to compare curves between wild-type and mutant strains

• For Western blot quantification, normalize band intensities to loading controls and apply ANOVA with post-hoc tests for multi-group comparisons

• When analyzing tRNA export efficiency, compare N:C ratios using appropriate statistical tests based on sample distribution (typically Student's t-test for pairwise comparisons)

Always report effect sizes alongside p-values and consider statistical power when interpreting negative results, particularly in experiments with subtle phenotypes.

How can researchers distinguish between direct effects of NUP100 disruption and secondary consequences in antibody-based studies?

To distinguish direct effects of NUP100 disruption from secondary consequences:

• Perform time-course experiments to establish temporal relationships between events

• Use domain-specific mutants (e.g., nup100Δ GLFG) rather than complete deletion to isolate functional domains

• Complement genetic approaches with acute interventions (e.g., rapid protein degradation systems)

• Compare phenotypes across multiple nucleoporin mutants to identify NUP100-specific versus general NPC disruption effects

• Conduct epistasis experiments by creating double mutants (e.g., nup100Δ gcn4Δ) to establish pathway relationships

• Use rescue experiments with wild-type NUP100 to confirm specificity of observed phenotypes

• Implement parallel assays for nuclear pore integrity and general nucleocytoplasmic transport

For example, comparing tRNA export defects between nup100Δ and other nucleoporin mutants (los1Δ, msn5Δ) revealed that distinct tRNAs accumulate in different mutant backgrounds, indicating nucleoporin-specific functions in tRNA export .

How do applications of NUP100 antibodies compare to antibodies against other nucleoporins like NUP214?

NUP100 antibodies and NUP214 antibodies serve distinct research purposes based on their localization and function within the nuclear pore complex. NUP214 antibodies target a protein located at the cytoplasmic side of the NPC that functions as a docking site for receptor-mediated import and is involved in processes like adenovirus capsid disassembly . In contrast, NUP100 antibodies detect a protein primarily involved in tRNA export and aging in yeast models .

For experimental applications:

• NUP214 antibodies are commonly used in immunoprecipitation (IP) and Western blot (WB) analyses, with validated reactivity against human and mouse samples

• NUP100 antibodies are frequently applied in yeast models for studying tRNA trafficking and replicative lifespan

• Both can be used in immunofluorescence, but with different expected localization patterns reflecting their distinct positions within the NPC architecture

The choice between these antibodies should be guided by the specific biological question and model system under investigation.

What unique insights can be gained from combining NUP100 antibodies with advanced microscopy techniques like Pan-Expansion Microscopy?

Combining NUP100 antibodies with Pan-Expansion Microscopy (Pan-ExM) offers several unique advantages:

• Ultra-high resolution visualization of NUP100 positioning within the three-dimensional architecture of the nuclear pore complex

• Ability to resolve individual NPCs and quantify NUP100 distribution across different NPC substructures

• Direct assessment of antibody labeling efficiency by comparing NUP100-specific signals to pan-NPC staining

• Capacity to detect potential heterogeneity in NUP100 composition among different NPCs within the same nucleus

• Improved accessibility for antibodies through the expanded sample matrix, enhancing detection of epitopes that might be masked in conventional preparations

These approaches enable researchers to move beyond bulk analyses and examine NPC composition and structure at the single-pore level, providing insights into potential functional heterogeneity among NPCs .

What emerging research areas might benefit from NUP100 antibody applications?

Emerging research areas that could benefit from NUP100 antibody applications include:

• Single-cell analysis of nuclear pore complex heterogeneity across different cell types and states

• Investigation of nucleoporin dynamics during cellular stress responses and aging

• Development of targeted therapies for diseases involving nucleoporin dysfunction

• Study of nuclear pore complex remodeling during cellular differentiation processes

• Exploration of NUP100 homologs in mammalian systems and their potential roles in RNA transport

• Research into nuclear pore complex assembly and disassembly during cell cycle progression

• Investigation of post-translational modifications of nucleoporins and their functional consequences

As microscopy technologies continue to advance, combining NUP100 antibodies with techniques like Pan-ExM will enable increasingly detailed structural and functional analyses of the nuclear pore complex at unprecedented resolution .

How might future developments in antibody technology enhance NUP100 research?

Future developments in antibody technology that could enhance NUP100 research include:

• Development of site-specific nanobodies with improved penetration into nuclear pore complex structures

• Creation of conformation-specific antibodies that distinguish between different functional states of NUP100

• Implementation of split-antibody complementation systems to detect specific NUP100 interactions in living cells

• Design of antibody-based biosensors that report on NUP100 conformational changes or post-translational modifications

• Integration of photoactivatable antibodies for super-resolution imaging with precise temporal control

• Development of bivalent antibodies simultaneously targeting NUP100 and interacting partners

• Creation of recyclable antibody systems for sequential detection of multiple nucleoporins in the same sample